Suszko Magdalena I, Balkin Daniel M, Chen Yan, Woodruff Teresa K
Department of Neurobiology and Physiology, Northwestern University, 2205 Tech Drive, Evanston, IL 60208 USA.
Mol Endocrinol. 2005 Jul;19(7):1849-58. doi: 10.1210/me.2004-0475. Epub 2005 Mar 10.
Synthesis of FSH by the anterior pituitary is regulated by activin, a member of the FSH(beta) superfamily of ligands. Activin signals through a pathway that involves the activation of the transcriptional coregulators Smad2 and Smad3. Previous work from our laboratory demonstrated that Smad3, and not Smad2, is sufficient for stimulation of the rat FSH(beta) promoter in a pituitary-derived cell line L(beta)T2. Here, we used RNA interference technology to independently decrease the expression of Smad proteins in L(beta)T2 cells to further investigate Smad2 and Smad3 roles in activin-dependent regulation of the FSHbeta promoter. Down-regulation of Smad2 protein by small interfering RNA duplexes affects only basal transcription of FSH(beta), whereas decreased expression of Smad3 abrogates activin-mediated stimulation of FSH(beta) transcription. Although highly related, Smad2 and Smad3 differ in their Mad homolog (MH) 1 domains, where the Smad2 protein contains two additional stretches of amino acids that prevent this factor from binding to DNA. We investigated whether these structural features contribute to differential FSH(beta) transactivation by Smad2 and Smad3. A variety of Smad chimera constructs were generated and used in transient transfection studies to address this question. Only cotransfection of chimera constructs that contain the MH1 domain of Smad3 results in activin-mediated stimulation of the rat FSH(beta) promoter. Furthermore, the insertion of Smad2 loops into Smad3 protein renders it inactive, suggesting that DNA binding is necessary for Smad3-mediated stimulation of the rat FSH(beta) promoter. Taken together, these results indicate that the functional differences between Smad2 and Smad3 in their ability to transactivate the rat FSH(beta) promoter lie primarily within the MH1 domain and involve structural motifs that affect DNA binding.
垂体前叶合成促卵泡激素(FSH)受激活素调控,激活素是FSH(β)超家族配体成员之一。激活素通过一条涉及转录共调节因子Smad2和Smad3激活的信号通路发挥作用。我们实验室之前的研究表明,在垂体来源的细胞系L(β)T2中,Smad3而非Smad2足以刺激大鼠FSH(β)启动子。在此,我们运用RNA干扰技术在L(β)T2细胞中独立降低Smad蛋白的表达,以进一步研究Smad2和Smad3在激活素依赖的FSHβ启动子调控中的作用。小干扰RNA双链体下调Smad2蛋白仅影响FSH(β)的基础转录,而Smad3表达降低则消除了激活素介导的FSH(β)转录刺激。尽管Smad2和Smad3高度相关,但它们的Mad同源(MH)1结构域存在差异,Smad2蛋白在该结构域包含两段额外的氨基酸序列,这阻止了该因子与DNA结合。我们研究了这些结构特征是否导致Smad2和Smad3对FSH(β)的转录激活存在差异。我们构建了多种Smad嵌合体,并用于瞬时转染研究以解决这个问题。只有共转染包含Smad3的MH1结构域的嵌合体构建体才会导致激活素介导的大鼠FSH(β)启动子刺激。此外,将Smad2的环插入Smad3蛋白会使其失活,这表明DNA结合对于Smad3介导的大鼠FSH(β)启动子刺激是必需的。综上所述,这些结果表明Smad2和Smad3在激活大鼠FSH(β)启动子能力上的功能差异主要存在于MH1结构域,并涉及影响DNA结合的结构基序。